Table 2 Chest CT index of the two groups
From: Severity of COVID-19 infection in patients with COVID-19 combined with diabetes
Variable | Good blood glucose control group (N = 53) | Poor blood glucose control group (N = 93) | Statistics | P |
|---|---|---|---|---|
CTSS score/score | 10.38 ± 4.84 | 13.30 ± 5.25 | -3.326① | 0.001 |
Lung lobe score/score | ||||
Left upper lobe | 2(1 ∼ 2.5) | 2(1 ∼ 3) | -2.790② | 0.005 |
Left lower lobe | 3(2 ∼ 4) | 3(2 ∼ 4) | -2.363② | 0.118 |
Right upper lobe | 2(1 ∼ 2) | 2(1 ∼ 3) | -2.661② | 0.008 |
Right middle lobe | 1(1 ∼ 2) | 2(1 ∼ 3) | -2.736② | 0.006 |
Right lower lobe | 3(2 ∼ 4) | 3(2 ∼ 4) | -2.567② | 0.010 |
Pleural effusion/case | 0.643③ | 0.423 | ||
Yes | 17(32%) | 36(39%) | ||
No | 36(68%) | 57(61%) | ||
Consolidation/case | 1.467③ | 0.226 | ||
Yes | 30(57%) | 62(67%) | ||
No | 23(43%) | 31(33%) | ||
Ground glass opacity/case | 2.567③ | 0.109 | ||
Yes | 40(75%) | 80(86%) | ||
No | 13(25%) | 13(14%) | ||
Crazy-paving sign/case | 3.557③ | 0.590 | ||
Yes | 15(28%) | 41(44%) | ||
No | 38(72%) | 52(56%) | ||